Miller RE - Search Results

1

Body Mass Index and Outcomes in Germ-Cell Tumors.

McGregor BA, Miller RE, O'Donnell E, Albiges LK, Sweeney CJ, Markt SC. McGregor BA, et al. Among authors: miller re. Clin Genitourin Cancer. 2019 Aug;17(4):283-290. doi: 10.1016/j.clgc.2019.04.012. Epub 2019 Apr 25. Clin Genitourin Cancer. 2019. PMID: 31129146

2

Chemotherapy for metastatic castrate-sensitive prostate cancer.

Miller RE, Sweeney CJ. Miller RE, et al. Prostate Cancer Prostatic Dis. 2016 Jun;19(2):139-44. doi: 10.1038/pcan.2016.10. Epub 2016 Mar 15. Prostate Cancer Prostatic Dis. 2016. PMID: 26976365 Review.

3

Insurance status and disparities in disease presentation, treatment, and outcomes for men with germ cell tumors.

Markt SC, Lago-Hernandez CA, Miller RE, Mahal BA, Bernard B, Albiges L, Frazier LA, Beard CJ, Wright AA, Sweeney CJ. Markt SC, et al. Among authors: miller re. Cancer. 2016 Oct 15;122(20):3127-3135. doi: 10.1002/cncr.30159. Epub 2016 Aug 8. Cancer. 2016. PMID: 27500561 Free PMC article.

4

Age ≥40 Years Is Associated with Adverse Outcome in Metastatic Germ Cell Cancer Despite Appropriate Intended Chemotherapy.

Miller RE, Markt SC, O'Donnell E, Bernard B, Albiges LK, Beard C, Sweeney CJ. Miller RE, et al. Eur Urol Focus. 2017 Dec;3(6):621-628. doi: 10.1016/j.euf.2016.10.005. Epub 2016 Oct 26. Eur Urol Focus. 2017. PMID: 28753801

5

Smoking and Disease Outcomes in Patients With Malignant Germ Cell Tumors.

O'Donnell E, Markt SC, Miller R, Bernard B, Albiges L, Beard C, Sweeney C. O'Donnell E, et al. Clin Genitourin Cancer. 2017 Aug 3:S1558-7673(17)30234-3. doi: 10.1016/j.clgc.2017.07.024. Online ahead of print. Clin Genitourin Cancer. 2017. PMID: 28851592

6

Surgical management and outcomes for stage 1 malignant ovarian germ cell tumours: A UK multicentre retrospective cohort study.

Graham R, MacDonald ND, Lockley M, Miller R, Butler J, Murali K, Sarker SJ, Banerjee S, Stoneham S, Shamash J, Liberale V, Berney DM, Newton C. Graham R, et al. Eur J Obstet Gynecol Reprod Biol. 2022 Apr;271:138-144. doi: 10.1016/j.ejogrb.2022.02.013. Epub 2022 Feb 16. Eur J Obstet Gynecol Reprod Biol. 2022. PMID: 35192975

7

Pathological findings after primary chemotherapy in patients undergoing simultaneous orchidectomy and retroperitoneal lymph node dissection for advanced germ cell tumours.

Miller RE, Dudderidge T, Huddart R, Seckl MJ, Rustin GJ, Christmas TJ. Miller RE, et al. BJU Int. 2013 Apr;111(4 Pt B):E152-7. doi: 10.1111/j.1464-410X.2012.11537.x. Epub 2012 Sep 27. BJU Int. 2013. PMID: 23016566

8

Real world outcomes in platinum sensitive relapsed ovarian, fallopian tube, or peritoneal cancer treated in routine clinical practice in the United Kingdom prior to poly-ADP ribose polymerase inhibitors.

Lord R, Rauniyar J, Morris T, Condon O, Jones R, Miller R, Hall M, Lofts F, Glasspool RM, Hudson E. Lord R, et al. Int J Gynecol Cancer. 2020 Jul;30(7):1026-1033. doi: 10.1136/ijgc-2019-000973. Epub 2020 Apr 21. Int J Gynecol Cancer. 2020. PMID: 32321768

9

Targeting HPV in gynaecological cancers - Current status, ongoing challenges and future directions.

Crusz SM, El-Shakankery K, Miller RE. Crusz SM, et al. Among authors: miller re. Womens Health (Lond). 2020 Jan-Dec;16:1745506520961709. doi: 10.1177/1745506520961709. Womens Health (Lond). 2020. PMID: 33296284 Free PMC article. Review.

10

Olaparib maintenance for first-line treatment of ovarian cancer: will SOLO1 reset the standard of care?

Miller RE, Crusz SM, Ledermann JA. Miller RE, et al. Future Oncol. 2019 Jun;15(16):1845-1853. doi: 10.2217/fon-2019-0057. Epub 2019 Apr 30. Future Oncol. 2019. PMID: 31037967

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

735 results

Search Page

Filters